Build A Bear Workshop Inc vs IDEXX Laboratories, Inc. — how do they compare? Build A Bear Workshop Inc trades at $37.1 (market cap $461.88M), while IDEXX Laboratories, Inc. trades at $573.76 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is far larger — about 100.1× Build A Bear Workshop Inc's market cap, and Build A Bear Workshop Inc pays a 2.5% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| BBW | IDXX | |
|---|---|---|
Market Cap | $461.88M | $46.22B |
Sector | Consumer Cyclical | Health |
52-Week High | $75.85 | $766.68 |
52-Week Low | $29.84 | $526.44 |
Enterprise Value | $561.32M | $47.12B |
Dividend Yield | 2.5% | — |
Signals from Pluang's Aura AI — not financial advice
Build-A-Bear Workshop (BBW) trades at $37.10, down 0.43% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company shows strong profitability with a 10.48% net margin and 35.87% ROE, supported by recent earnings beats. A new CEO transition and Halloween product launches aim to drive engagement, while analyst consensus is strongly bullish with a $62.50 price target.
BBW presents a compelling value opportunity with a low P/E of 8.63 and consistent earnings outperformance, though near-term revenue headwinds and consumer caution pose risks. The stock's 72.7% buy rating and debt-free balance sheet underpin upside potential, but investors should monitor execution of growth initiatives amid economic pressures.
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
Trailing returns across standard periods
Latest headlines on both assets
Build-A-Bear is a global retailer specializing in customizable stuffed animals. It offers an interactive make-your-own experience where customers choose, stuff, and dress their furry friends in-store or online.
Read more on BBW →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →